ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,301,373 | -9.0% | 210,171 | +10.1% | 0.00% | 0.0% |
Q2 2023 | $2,527,688 | +1.5% | 190,913 | +4.3% | 0.00% | 0.0% |
Q1 2023 | $2,490,167 | -30.1% | 182,966 | +0.3% | 0.00% | 0.0% |
Q4 2022 | $3,564,010 | +5.0% | 182,489 | +2.4% | 0.00% | 0.0% |
Q3 2022 | $3,394,000 | +9.2% | 178,167 | +18.1% | 0.00% | 0.0% |
Q2 2022 | $3,108,000 | -33.7% | 150,879 | +3.5% | 0.00% | 0.0% |
Q1 2022 | $4,690,000 | -29.4% | 145,749 | +2.2% | 0.00% | -50.0% |
Q4 2021 | $6,639,000 | +75.0% | 142,575 | +1.5% | 0.00% | +100.0% |
Q3 2021 | $3,794,000 | +52.3% | 140,518 | +44.7% | 0.00% | 0.0% |
Q2 2021 | $2,491,000 | -22.3% | 97,086 | +3.6% | 0.00% | 0.0% |
Q1 2021 | $3,204,000 | +26.7% | 93,712 | +25.4% | 0.00% | 0.0% |
Q4 2020 | $2,529,000 | +48.2% | 74,751 | +8.1% | 0.00% | 0.0% |
Q3 2020 | $1,706,000 | – | 69,141 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |